Tin tức & Cập nhật

Antimicrobial prophylaxis does not prevent UTI after transurethral resection of bladder tumour

20 Apr 2021 bởi

Use of antimicrobial prophylaxis (AMP) appears to have no protective benefit against postoperative urinary tract infections (UTIs) or asymptomatic bacteriuria (ABU) in patients undergoing transurethral resection of bladder tumours (TURB), a recent study has shown.

Antimicrobial prophylaxis does not prevent UTI after transurethral resection of bladder tumour

20 Apr 2021

Male voiding behaviour varies daily, worsens with age

15 Apr 2021

Voiding parameters in older men vary from day to day, throughout the day, and worsen with age, as shown by an assessment of 19,824 uroflows using an accurate and precise home uroflow device.

Male voiding behaviour varies daily, worsens with age

15 Apr 2021

Pollen count rise triggers urological chronic pelvic pain syndrome flares

14 Apr 2021

Rising pollen count appears to trigger flares of urological chronic pelvic pain syndrome, suggests a study.

Pollen count rise triggers urological chronic pelvic pain syndrome flares

14 Apr 2021

Hormone therapy delivers nocturia benefit

14 Apr 2021

The benefit of using hormone therapy for menopause appears to extend to nocturia prevalence and bother, according to a study.

Hormone therapy delivers nocturia benefit

14 Apr 2021

Ureteral stenting ups risk of metachronous UTUC in bladder cancer

12 Apr 2021 bởi

Treatment with ureteral stenting in patients with bladder cancer, either to protect the ureteral orifice and prevent obstruction or to decompress established upper urinary tract (UUT) obstruction, appears to increase the risk of developing metachronous upper tract urothelial carcinoma (UTUC) compared with no stenting, results of a study have shown.

Ureteral stenting ups risk of metachronous UTUC in bladder cancer

12 Apr 2021

Enzalutamide tied to better outcomes than bicalutamide in mHSPC

09 Apr 2021 bởi

A regimen comprising enzalutamide and androgen deprivation therapy (ADT) led to better outcomes compared with a bicalutamide-ADT regimen in an earlier setting of metastatic hormone-sensitive prostate cancer (mHSPC), particularly in Black men, a phase II study suggests.

Enzalutamide tied to better outcomes than bicalutamide in mHSPC

09 Apr 2021

New oral TRT exhibits favourable safety, efficacy for hypogonadal men

07 Apr 2021 bởi

A novel oral testosterone replacement therapy (TRT*) formulation – testosterone undecanoate (TU) – showed favourable safety and efficacy as long-term treatment for men with low testosterone levels, according to the extension phase results of a study presented at ENDO 2021.

New oral TRT exhibits favourable safety, efficacy for hypogonadal men

07 Apr 2021

Risk factors for hospital readmission in survivors of complicated UTI

03 Apr 2021

Survivors of complicated urinary tract infections (cUTI) are commonly readmitted for recurrent UTI, usually related to other medical conditions that require urinary interventions, a recent study has found.

Risk factors for hospital readmission in survivors of complicated UTI

03 Apr 2021

Original New Drug Application Approvals by US FDA (16 - 31 March 2021)

01 Apr 2021

New drug applications approved by US FDA as of 16-31 March 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16 - 31 March 2021)

01 Apr 2021

Cabozantinib improves PFS, response in metastatic papillary RCC

23 Mar 2021 bởi

In patients with metastatic papillary renal cell carcinoma (PRCC), cabozantinib led to greater progression-free survival (PFS) and overall response rate (ORR) than sunitinib, results of the phase II SWOG 1500 study showed.

Cabozantinib improves PFS, response in metastatic papillary RCC

23 Mar 2021

Tin tức & Cập nhật

Lọc theo Chuyên ngành:

Chuyên ngành:

Antimicrobial prophylaxis does not prevent UTI after transurethral resection of bladder tumour

Antimicrobial prophylaxis does not prevent UTI after transurethral resection of bladder tumour

Male voiding behaviour varies daily, worsens with age

Male voiding behaviour varies daily, worsens with age

Pollen count rise triggers urological chronic pelvic pain syndrome flares

Pollen count rise triggers urological chronic pelvic pain syndrome flares

Hormone therapy delivers nocturia benefit

Hormone therapy delivers nocturia benefit

Ureteral stenting ups risk of metachronous UTUC in bladder cancer

Ureteral stenting ups risk of metachronous UTUC in bladder cancer

Enzalutamide tied to better outcomes than bicalutamide in mHSPC

Enzalutamide tied to better outcomes than bicalutamide in mHSPC

New oral TRT exhibits favourable safety, efficacy for hypogonadal men

New oral TRT exhibits favourable safety, efficacy for hypogonadal men

Risk factors for hospital readmission in survivors of complicated UTI

Risk factors for hospital readmission in survivors of complicated UTI

Original New Drug Application Approvals by US FDA (16 - 31 March 2021)

Original New Drug Application Approvals by US FDA (16 - 31 March 2021)

Cabozantinib improves PFS, response in metastatic papillary RCC

Cabozantinib improves PFS, response in metastatic papillary RCC